MedTrace Logo

Chronic Pain Rehabilitation in Patients With Small Fiber Neuropathy

NCT05798949 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-04-05

No results posted yet for this study

Summary

Small fiber neuropathy (SFN) is a condition that is dominated by invalidating neuropathic pain. Pharmacological neuropathic pain treatment is often disappointing, since pain reduction is mostly slight and side effects can be debilitating. Although neuropathic pain is caused by a lesion of the somatosensory system, also psychological factors, such as fear and catastrophizing, appear to play a role in the origin and maintenance of disability in chronic pain. Rehabilitation based on pain education and cognitive behavioral treatment including elements of acceptance and commitment therapy, exposure in vivo or graded activity can be performed to influence these factors. To date no specific rehabilitation programs are available for patients diagnosed with SFN.

Conditions

  • Small Fiber Neuropathy

Interventions

BEHAVIORAL

Chronic pain rehabilitation: exposure in vivo

Behavioral, chronic pain rehabilitation therapy

BEHAVIORAL

Chronic pain rehabilitation: graded activity

Behavioral, chronic pain rehabilitation therapy

BEHAVIORAL

Chronic pain rehabilitation: acceptance and commitment therapy

Behavioral, chronic pain rehabilitation therapy

Sponsors & Collaborators

  • Academisch Ziekenhuis Maastricht

    lead OTHER

Principal Investigators

  • J. AC Verbunt, MD, PhD · Adelante Zorggroep

  • J. GJ Hoeijmakers, MD, PhD · Maastricht University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-09
Primary Completion
2025-10-31
Completion
2025-10-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05798949 on ClinicalTrials.gov